Logo for Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Investor Relations Material

Latest events

Logo for Aurinia Pharmaceuticals Inc

Study Result

Aurinia Pharmaceuticals
Logo for Aurinia Pharmaceuticals

Study Result

30 Jun, 2025
Logo for Aurinia Pharmaceuticals

Corporate Presentation

10 Jun, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Aurinia Pharmaceuticals Inc

Access all reports
Aurinia is a biopharmaceutical company driven by a relentless commitment to bring life-changing therapies, like voclosporin, to patients suffering from diseases with high unmet medical need. The Company’s lead product, voclosporin, is being investigated as a therapy for LN. The Company is initially targeting LN and has plans to study additional disease indications. The company is headquartered in Victoria, Canada.